Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy

Pediatric Infectious Disease Journal

Volumn 15, Issue 6, 1996, Pages 530-535

  Kurikka, Sari ^a   Ölander, Rose Marie ^a   Eskola, Juhani ^a   Käyhty, Helena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

conjugate vaccines; Haemophilus influenzae type b vaccination; maternal antibodies; tetanus antibodies

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; TETANUS ANTIBODY; TETANUS TOXOID;

ANTIBODY RESPONSE; ARTICLE; DIPHTHERIA; DOSE RESPONSE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; SAFETY; SEROCONVERSION; STATISTICAL ANALYSIS; TETANUS; VACCINATION;

ANTIBODIES, BACTERIAL; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOCOMPETENCE; INFANT; TETANUS; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 0029951863     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199606000-00011     Document Type: Article

References (26)

1. Sato, Albrecht P, Reynolds D, Stagno S, Ennis F. Transfer of measles, mumps, and rubella antibodies from mother to infant. Am J Dis Child 1979;133:1240-3.
2. Booy R, Aiken SJM, Taylor S, et al. Immunogenicity of combined diphtheria, tetanus, and pertussis-vaccine given at 2, 3 and 4 months versus 3, 5, and 9 months of age. Lancet; 339:507-10.
3. Daum RS, Siber GR, Ballanco GA, Sood SK. Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Infect Dis 1991;164:1154-9.
4. Claesson BA, Schneerson R, Robbins JB, et al. Protective levels of serum antibodies stimulate in infants by two injections of Haemophilus influenzae type b capsular polysaccharide tetanus toxoid conjugate. J Pediatr 1989;114:97-100.
5. Barington T, Gyhrs A, Kristensen K, Heilman C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1994;62:9-14.
6. Sarvas H, Kurikka S, Soppälä IJT, Mäkelä PH, Mäkelä O. Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J Infect Dis 1992;165:977-9.
7. Siber GR, Werner BG, Halsey NA, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr 1993;122:204-11.
8. Siber GR, Thompson C, Reid RG, et al. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J Infect Dis 1992;165(Suppl. 1):29-33.
9. Singleton RJ, Davidson NM, Desmet IJ, et al. Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization. Pediatr Infect Dis J 1994;13:362-7.
10. Letson GW, Santosham M, Reid R, et al. Comparison of active and combined passive/active immunization of Navajo children against Haemophilus influenzae type b. Pediatr Infect Dis J 1988;7:747-52.
11. Beasley RP, Hwang LY, Lee GCY, et al. Prevention of perinatally transmitted hepatitis B infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-102.
12. Katz DH, Paul WE, Goidi EA, Benacerraf B. Carrier function in anti-hapten immune responses: I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization. J Exp Med 1970;132:261-82.
13. Schneerson R, Robbins JB, Chu C, et al. Serum antibody response of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type A capsular polysaccharide-protein conjugates. Infect Immun 1984;45:582-91.
14. Barington T, Kistensen K, Henrichsen J, Heilmann C. Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzas type b conjugate vaccine. Infect Immun 1991;59:1057-64.
15. Etlinger HM, Felix AM, Gillessen D, et al. Assesment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. J Immunol 1988;140:626-33.
16. Suara RO, Jaffar S, N'Jie J, et al. The effect of prior tetanus vaccination and other factors on responses to PRP-T conjugate vaccine in pregnant Gambian women [Abstract G11]. In: Program and abstracts of the 34th Interscience Congress on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4 to 7, 1994. Washington, DC: American Society for Microbiology, 1994.
17. Mäkelä PH, Peltola H, Käyhty H, et al. Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzas type b: a field trial in Finland. J Infect Dis 1977;190(Suppl.):43-50.
18. Kurikka S, Käyhty H, Peltola H, Saarinen L, Eskola J, Mäkelä PH. Neonatal immunization: response to Haemophilus influenzas, type b-tetanus toxoid conjugate vaccine. Pediatrics 1995;95:815-22.
19. Voller A, Bidwell DE, Bartlett A. The enzyme-linked immunosorbent assay (ELISA). London: The Zoological Society of London, 1977.
20. Nohynek H, Capeding R, Käyhty H, Ölander RM, Pascual L, Ruutu P. Maternal antitetanus antibodies does not depress responses to Haemophilus influenzae type b (Hib) tetanus conjugate vaccine (PRP-T). [Abstract G19]. In: Program and abstracts of the 34th Interscience Congress on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4 to 7, 1994. Washington, DC: American Society for Microbiology, 1994.
21. Stein KE, Söderström T. Neonatal administration of idiotype or anti-idiotype primes for protection against E. coli K13 infection in mice. J Exp Med 1984;160:1001-11.
22. UytdeHaag FG, Osterhaus AD. Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody. J Immunol 1985;134:1225-9.
23. Gill TJ, Repetti CF, Metaly LA, et al. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 1983;72:987-96.
24. Hahn-Zoric M, Carlsson B, Jeansson S, et al. Anti-idiotypic antibodies to poliovirus antibodies in commercial immunoglobulin preparations, human serum, and milk. Pediatr Res 1993;33:475-80.
25. Mellander L, Carlsson B, Hanson LÅ. Secretory IgA and IgM antibodies to E. coli O and poliovirus type 1 antigens occur in amniotic fluid, meconium and saliva from newborns: a neonatal immune response without antigenic exposure: a result of anti-idiotypic induction? Clin Exp Immunol 1986;63:555-61.
26. Hahn-Zoric M, Carlsson B, Björkander J, Osterhaus AD, Mellander L, Hanson LA. Presence of non-maternal antibodies in newborns of mothers with antibody deficiencies. Pediatr Res 1992;32:150-4.